HIV treatment programmes lose their impact if they do not help people engage with medical care after an HIV diagnosis and stay in contact with HIV services. Improving retention and linkage to care is crucial to improving outcomes along the HIV treatment cascade.

Retention and linkage to care: latest news

Retention and linkage to care resources

Retention and linkage to care features

Retention and linkage to care news from aidsmap

More news

Retention and linkage to care news selected from other sources

  • US: 80% of new HIV cases transmitted by undiagnosed or untreated people

    In 2016, more than 80% of new HIV infections in the United States were transmitted by individuals who either did not know they were infected with HIV or had been diagnosed but were not receiving care, according to data released on the first day of the National HIV Prevention Conference in Atlanta.

    23 hours ago | Healio
  • Trump’s Proposed Budget Undermines His H.I.V. Plan, Experts Say

    Strategies abound to end the AIDS epidemic, but expense — mostly for drugs costing up to $50,000 a year — is the inevitable obstacle.

    14 March 2019 | The New York Times
  • South Africa: The problem of stopping or not starting HIV treatment

    South Africa has the largest HIV epidemic in the world. The United Nations Programme on HIV/AIDS (UNAIDS) estimates that there are approximately 7.2-million South Africans living with HIV, with 270 000 new HIV infections in 2017. South Africa also has the largest antiretroviral therapy (ART) programme with more than four million people estimated to be on treatment. Despite progress in getting people onto treatment, recent evidence indicates that the country is still experiencing significant numbers of people developing and dying from advanced HIV-disease. This is as result of people who either do not start treatment, start treatment late, or stop and re-start treatment. There is, therefore, an urgent need to not only prioritise HIV-testing but to ensure that once people start treatment, they remain on life-long care.

    12 March 2019 | Spotlight
  • India’s first LGBTQ clinic and HIV treatment centre inaugurated in Mumbai

    Based out of the Humsafar Trust’s office jn Mumbai, the centre will give free counselling and provide Anti-Retroviral Therapy (ART) to the LGBTQ community. TAshok Row Kavi, founder chairperson of the Trust, said: “Until now we would get testing done for the community members at our centre. If tested positive for the disease, they would be asked to go to Sion Hospital, but there was a huge dropout (rate) there. Because of how the community is perceived outside, a lot of these people wouldn’t seek treatment."

    12 March 2019 | Hindustan Times
  • Researchers Report High Rate of Viral Suppression Among People New to HIV Care

    Eighty-six percent of individuals who entered HIV care soon after diagnosis maintained viral suppression after 48 weeks during a clinical trial conducted at four National Institutes of Health (NIH)-funded Centers for AIDS Research (CFARs) across the United States. Participants in the clinical trial, called iENGAGE, achieved viral suppression in an average of just 63 days. The findings were presented in a poster at the Conference on Retroviruses and Opportunistic Infections (link is external) (CROI 2019) in Seattle.

    08 March 2019 | NIAID
  • San Francisco Is Beating H.I.V. Why Can’t Houston?

    We know how to fight the epidemic, but patients in the South still aren’t getting the treatment they need.

    04 March 2019 | The New York Times
  • Viral load monitoring motivates HIV treatment adherence in eSwatini

    The treat-all policy will only succeed if people keep taking their HIV treatment. It is important to motivate people who started treatment while they were still feeling well. 

    24 February 2019 | AVERT
  • Viral Load Does Not Equal Value

    Are We Shaming Those Who Are Detectable? To contend with this issue and fight the epidemic, we must confront structural barriers and address stigma. What’s more, we must imagine new ways to provide community support beyond offering only clinical solutions.

    20 February 2019 | POZ
  • What stops people with HIV adhering to long term antiretroviral therapy?

    Long term adherence to antiretroviral therapy (ART) is important in both reducing morbidly and mortality in people living with HIV and reducing transmission rates. A new study published in AIDS Research and Therapy explores people’s reasons for non-adherence to ART through a cohort in Uganda. They find travel, stigma, poor adherence education, and alternative medicine to be prominent factors.

    22 January 2019 | BMC Blogs Network
  • HIV care: Karnataka bags top spot

    When it comes to providing care, support and treatment to HIV patients, Karnataka has been judged the best performer among states with a high HIV burden.

    16 January 2019 | Times of India
More news
Tell us why you visited aidsmap today
minimise

Could you help us by answering three questions on why you’ve visited aidsmap today?

You can close this questionnaire and come back to it later. Just click on the pink circle.

What prompted you to visit aidsmap today?

What exactly are you looking for? What specific questions do you need answered?

Have you found what you were looking for?

close

Thank you for your feedback

Thank you very much for taking time to fill in this questionnaire. NAM really values your feedback. It helps make the information we provide better.

If you have any other comments on the content of this website, we would be interested to hear from you. Please email info@nam.org.uk.

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.